218 related articles for article (PubMed ID: 22770648)
1. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
Kump PK; Högenauer C; Wenzl HH; Petritsch W
J Crohns Colitis; 2013 Feb; 7(1):e15-8. PubMed ID: 22770648
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab.
Fallon JC; Patchett S; Gulmann C; Murphy GM
Clin Exp Dermatol; 2008 Jan; 33(1):43-5. PubMed ID: 17983451
[TBL] [Abstract][Full Text] [Related]
3. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.
Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635
[No Abstract] [Full Text] [Related]
4. Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy.
Ramos JM; García-Sepulcre MF; Rodríguez JC; Padilla S; Gutiérrez F
J Med Microbiol; 2010 May; 59(Pt 5):617-621. PubMed ID: 20133411
[TBL] [Abstract][Full Text] [Related]
5. [A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].
Guyot A; Begon E; Abramowitz L; Landry J; Marinho E; Descamps V; Crickx B
Ann Dermatol Venereol; 2009 Nov; 136(11):806-10. PubMed ID: 19917434
[TBL] [Abstract][Full Text] [Related]
6. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
[No Abstract] [Full Text] [Related]
7. Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions.
Honda Y; Tanizaki H; Otsuka A; Shirakashi M; Imura Y; Mimori T; Miyachi Y; Kabashima K
Acta Derm Venereol; 2015 Nov; 95(8):1028-9. PubMed ID: 25881714
[No Abstract] [Full Text] [Related]
8. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
McDonnell MJ; Rutherford RM; O'Regan A
J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
[No Abstract] [Full Text] [Related]
9. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
[TBL] [Abstract][Full Text] [Related]
10. Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study.
van der Have M; Belderbos TD; Fidder HH; Leenders M; Dijkstra G; Peters CP; Eshuis EJ; Ponsioen CY; Siersema PD; van Oijen MG; Oldenburg B;
Dig Liver Dis; 2014 Oct; 46(10):881-6. PubMed ID: 25081843
[TBL] [Abstract][Full Text] [Related]
11. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.
Asakura T; Ishii M; Kikuchi T; Kameyama K; Namkoong H; Nakata N; Sugita K; Tasaka S; Shimizu T; Hoshino Y; Okamoto S; Betsuyaku T; Hasegawa N
Medicine (Baltimore); 2016 Mar; 95(11):e3131. PubMed ID: 26986167
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
[No Abstract] [Full Text] [Related]
13. Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease.
Levesque BG; Sandborn WJ
Inflamm Bowel Dis; 2011 Jun; 17(6):1443-4. PubMed ID: 21560204
[No Abstract] [Full Text] [Related]
14. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.
Cesarini M; Angelucci E; Foglietta T; Vernia P
J Crohns Colitis; 2011 Dec; 5(6):619-22. PubMed ID: 22115384
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab for the treatment of pediatric Crohn's disease.
Nuti F; Fiorino G; Danese S
Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab.
Ferreira J; Grochowsky J; Krakower D; Zuromskis P; Baden R; Cheifetz AS
Am J Gastroenterol; 2012 Aug; 107(8):1268-9. PubMed ID: 22859009
[No Abstract] [Full Text] [Related]
18. Mycobacterium marinum with associated bursitis.
Saadatmand B; Poulton JK; Kauffman CL
J Cutan Med Surg; 1999 Apr; 3(4):218-20. PubMed ID: 10366400
[TBL] [Abstract][Full Text] [Related]
19. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
[TBL] [Abstract][Full Text] [Related]
20. A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual.
Seneviratne K; Herieka E
Int J STD AIDS; 2013 Jan; 24(1):75-7. PubMed ID: 23512514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
